COVID-19 convalescent plasma, the latest hyped treatment for patients suffering with the disease, has received FDA emergency authorization. However, rigorous randomized, placebo-controlled studies have yet to be completed, written up, peer-reviewed, and published in a scientific journal. Even if plasma is ultimately shown to be both efficacious and safe for treatment purposes, the supply will always be limited by the number of recovered patients who donate plasma. Thus, this treatment is neither very scalable nor likely to stop the spread of the coronavirus. An ounce of prevention is still worth a pound of cure!!